Nursing patients with mCRPC presents considerable challenges to nurses.
They need to draw upon a variety of skills to support and care for patients throughout the disease journey. As the majority of patients with mCRPC are elderly, they tend to have co-morbidities and possibly side effects from previous treatment that need consideration. Some patients will present at around 50 years of age and will also have specific, different needs. The majority of patients with mCRPC will have bone metastases that may cause disability and pain. The International Society of Geriatric Oncology (SIOG) has recommended that older men are treated according to health status and not chronological age. So nurses need to understand how to assess patients' status effectively, regardless of their age. This will enable nurses to provide appropriate and effective intervention and to support their patients during treatment for advancing disease. This article reviews the main methods of assessment and the nursing interventions for the common side effects associated with treatment for mCRPC.
Written by:
Sonnek FC, Muilekom Ev. Are you the author?
Ecole de formation Européenne en cancérologie, Fédération Nationale des Centres de Lutte Contre le Cancer (EFEC-FNCLCC) Paris; Centre Paul Strauss, Strasbourg, France; Clinical Nurse Specialist, Netherlands Cancer Institute.
Reference: Eur J Oncol Nurs. 2013 Sep;17 Suppl 1:S7-S12.
doi: 10.1016/S1462-3889(14)70003-1
PubMed Abstract
PMID: 24461208
UroToday.com mCRPC Treatment Section
